Bibliographic Details
| Title: |
T-Cell Engagers - Modern Immune-Based Therapies for Multiple Myeloma. |
| Authors: |
Mailankody S; From the Myeloma and Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (S.M.); and the Division of Myeloma, Sylvester Comprehensive Cancer Center, University of Miami, Miami (O.L.)., Landgren O; From the Myeloma and Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (S.M.); and the Division of Myeloma, Sylvester Comprehensive Cancer Center, University of Miami, Miami (O.L.). |
| Source: |
The New England journal of medicine [N Engl J Med] 2022 Aug 11; Vol. 387 (6), pp. 558-561. |
| Publication Type: |
Editorial; Comment |
| Language: |
English |
| Journal Info: |
Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE |
| Imprint Name(s): |
Original Publication: Boston, Massachusetts Medical Society. |
| MeSH Terms: |
Immunotherapy*/methods , Immunotherapy*/trends , Multiple Myeloma*/drug therapy , Multiple Myeloma*/immunology , Multiple Myeloma*/therapy , T-Lymphocytes*/immunology, Humans ; Immunotherapy, Adoptive |
| Comments: |
Comment on: N Engl J Med. 2022 Aug 11;387(6):495-505. (PMID: 35661166) |
| Entry Date(s): |
Date Created: 20220810 Date Completed: 20220812 Latest Revision: 20220818 |
| Update Code: |
20221216 |
| DOI: |
10.1056/NEJMe2209692 |
| PMID: |
35947712 |
| Database: |
MEDLINE |